Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography
- 1 January 1994
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 21 (1), 17-22
- https://doi.org/10.1007/bf00182301
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- 99Tcm sestamibi — a new agent for parathyroid imagingNuclear Medicine Communications, 1989
- Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imagingThe American Journal of Cardiology, 1989
- Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methodsAmerican Heart Journal, 1989
- Editorial: The Evolving Role of Parathyroid ScintigraphyClinical Nuclear Medicine, 1989
- Diagnosis of recurrent hyperparathyroidism: comparison of MR imaging and other imaging techniquesAmerican Journal of Roentgenology, 1988
- Parathyroid imaging: Its current status and future roleSeminars in Nuclear Medicine, 1987
- Localization of Abnormal Parathyroid Gland(s) Using Thallium-201 /lodine-123 Subtraction Scintigraphy in Patients with Primary HyperparathyroidismClinical Nuclear Medicine, 1986
- Assessment of thallium-pertechnetate subtraction scintigraphy in hyperparathyroidismThe British Journal of Radiology, 1985
- A New Method with High Sensitivity and Specificity for Localization of Abnormal Parathyroid GlandsAnnals of Surgery, 1984
- Location of parathyroid adenomas by thallium-201 and technetium-99m subtraction scanning.BMJ, 1983